T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model

被引:41
作者
Stone, JD [1 ]
Cochran, JR [1 ]
Stern, LJ [1 ]
机构
[1] MIT, Dept Chem, Cambridge, MA 02139 USA
关键词
D O I
10.1016/S0006-3495(01)75899-7
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
T-cell activation is essential for initiation and control of immune system function. T cells are activated by interaction of cell-surface antigen receptors with major histocompatibility complex (MHC) proteins on the surface of other cells. Studies using soluble oligomers of MHC-peptide complexes and other types of receptor cross-linking agents have supported an activation mechanism that involves T cell receptor clustering. Receptor clustering induced by incubation of T cells with MHC-peptide oligomers leads to the induction of T-cell activation processes, including downregulation of engaged receptors and upregulation of the cell-surface proteins CD69 and CD25. Dose-response curves for these T-cell activation markers are bell-shaped, with different maxima and midpoints, depending on the valency of the soluble oligomer used. In this study, we have analyzed the activation behavior using a mathematical model that describes the binding of multivalent ligands to cell-surface receptors. We show that a simple equilibrium binding model accurately describes the activation data for CD4(+) T cells treated with MHC-peptide oligomers of varying valency. The model can be used to predict activation and binding behavior for T cells and MHC oligomers with different properties.
引用
收藏
页码:2547 / 2557
页数:11
相关论文
共 51 条
[1]   DIMERIZATION OF SOLUBLE MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE COMPLEXES IS SUFFICIENT FOR ACTIVATION OF T-CELL HYBRIDOMA AND INDUCTION OF UNRESPONSIVENESS [J].
ABASTADO, JP ;
LONE, YC ;
CASROUGE, A ;
BOULOT, G ;
KOURILSKY, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) :439-447
[2]  
Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023
[3]   Kinetics of T-cell receptor binding by bivalent HLA-DR•peptide complexes that activate antigen-specific human T-cells [J].
Appel, H ;
Gauthier, L ;
Pyrdol, J ;
Wucherpfennig, KW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) :312-321
[4]  
BEVINGTON PR, 1969, DATA REDUCTION ERROR, P242
[5]   Initiation of signal transduction through the T cell receptor requires the peptide multivalent engagement of MHC ligands [J].
Boniface, JJ ;
Rabinowitz, JD ;
Wülfing, C ;
Hampl, J ;
Reich, Z ;
Altman, JD ;
Kantor, RM ;
Beeson, C ;
McConnell, HM ;
Davis, MM .
IMMUNITY, 1998, 9 (04) :459-466
[6]   Receptor clustering as a cellular mechanism to control sensitivity [J].
Bray, D ;
Levin, MD ;
Morton-Firth, CJ .
NATURE, 1998, 393 (6680) :85-88
[7]   Cutting edge:: Detection of antigen-specific CD4+ T cells by HLA-DR1 oligomers is dependent on the T cell activation state [J].
Cameron, TO ;
Cochran, JR ;
Yassine-Diab, B ;
Sékaly, RP ;
Stern, LJ .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :741-745
[8]   T cell antigen receptor signal transduction pathways [J].
Cantrell, D .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :259-274
[9]   Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation [J].
Casares, S ;
Zong, CS ;
Radu, DL ;
Miller, A ;
Bona, CA ;
Brumeanu, TD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) :543-553
[10]   The expanding world of co-stimulation: the two-signal model revisited [J].
Chambers, CA .
TRENDS IN IMMUNOLOGY, 2001, 22 (04) :217-223